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Among the  endocrinopathies ,  d iabe tes  mel- 
l i tus  occupies  a unique position. In Addison's 
d i s e a s e ,  hypothyroidism, hypoparathyroidism, 
hypopituitarism a n d  o t h e r  def iciency s t a t e s ,  
there i s  a c lear  correlation between a hormonal 
deficiency and  the  pathologic anatomy. In dia- 
b e t e s  mell i tus ,  however, t h i s  i s  no t  the  c a s e .  
T h e  pancreas  may b e  relat ively normal from a 
morphologic point of view ' 0  l 7  except  for minor 
changes  which a r e  thought by many t o  b e  due  t o  
overstimulation of the  be ta  cel ls .  1 9 5 * 4 0 *  4 1 * 4 6  
One  explanat ion for th i s  incongruity could 
be that  insul in i s  p r o  d u  c e d normally i n  dia- 
be t ics  but des t royed  in a n  acce le ra ted  manner. 
Since insu l in  i s  e laborated into t h e  portal cir- 
culation a n d  must p a s s  t h r o u g h t h e  hepa t ic  
vascu la r  bed, considerable  at tent ion h a s  been 
focused on t h e  l iver  a s  a s i t e  of insu l in  deg- 
radation.7. 24-27 ,38 ,43 .44  
T h e  poss ib i l i ty  tha t  p a s s a g e  through the  
liver obtunds or a l t e r s  e f fec t iveness  of insul in 
h a s  potent ial  surg ica l  s ignif icance.  If t h e  con- 
cept  were proved, procedures for diversion of 
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pancrea t ic  venous drainage into sys temic  venous 
channe ls  could be devised,  thereby making more 
insu l in  ava i lab le  for peripheral t i s s u e s .  
The presen t  s tudy  w a s  undertaken to t e s t  
the  re la t ive  e f fec t iveness  of physiologic d o s e s  
of insul in administered into t h e  s y s t e m i c  circu- 
l a t ion  a s  compared t o  administration direct ly  
into the  l iver  v ia  the  portal vein. Comparison 
w a s  made of s low, cons tan t  insul in infusions 
al ternately administered to  a large s e r i e s  of d o g s  
by t h e s e  two routes. T h e  resu l t s  were ana lyzed  
s t a t i s t i c a l l y  u s i n g a n  electronic  digi ta l  computer. 
METHODS 
A to ta l  of 83 experiments  were performed in 
24 adul t ,  heal thy,  mongrel dogs,  from 12 t o  20 
kg., on which portacaval  t ransposi t ion had  been  
done two or more months previously. At the  time 
of t ransposi t ion,  a l l  venous t r ibutar ies  t o  the 
vena c a v a  were l iga ted  from the inguinal liga- 
ments  to  t h e  d i a p h r a g m ,  excep t ing  only the 
renals .  34  With th i s  preparation, in jec t ions  o r  
in fus ions  into t h e  vena  cava  or i t s  t r ibutar ies  
p a s s  into t h e  portal vein and  then through t h e  
liver. 34  In the p resen t  s tudy,  such  a n  infusion 
i s  termed "intraportal." T h e  hypoglycemic re- 
s p o n s e  to  intraportal infusions w a s  compared t o  
t h a t  ob ta ined  with forelimb ( sys temic)  insul in 
infusions. 
T h e  an imals  were fed  a s tandard  kenne l  ra- 
t ion of commercial dr ied dog  food supplemented 
with ground meat. Examinat ions were carr ied 
out a f te r  withholding food for 12 to 16 hours. In 
s e v e n  dogs ,  experiments  were carried ou t  on 
s u c c e s s i v e  days ,  u s i n g  a randomized order of 
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Fig. I .  Experimental preparation showing 
transposition of the portal vein and inferior vena 
cava and the posit ions of the ca theters  used.  1, Fore- 
leg catheter for s y s t e m i c  i n s u l i n  i n f u s i o n .  
2,Catheter in s ide  branch of femoral vein for infusion 
of insulin via inferior vena cava  which then leads  
into portal vein and liver ( i n  t r a p o r  t a 1 route). 
3,  Sampling catheter introduced through s ide  branch 
of femoral vein on opposite s ide  and threaded up the  
vena cava through vascular anastomosis into the  
portal vein. 4, Sampling catheter introduced into 
s ide  branch of femoral artery ~ n d  threaded into aorta. 
infusion route. Between experiments, the cath- 
e t e r s  were lef t  i n  p lace  and  p r o  t e c t e d with 
spec ia l ly  constructed jackets.  After a few d a y s ,  
the  an imals  became febrile,  presumably owing 
t o  the  continuous presence  of the  catheter .  Be- 
c a u s e  of d i ssa t i s fac t ion  with prolonged u s e  of 
indwelling ca the te rs ,  t h e s e  were removed be- 
tween e x p  e r  i m e n t s  i n  the other  17  animals. 
Response  to insul in in  this  s e r i e s  w a s  observed 
with a l t e rna te  rou tes  of administration every 
f ive  to  s e v e n  days  rather  than daily. 
Experiments  were performed on unanesthe-  
t i zed  dogs  t r a i n  e d to  l i e  quietly during the 
experiment. T h e  infusion catheters  were inser ted 
into ei ther  the  vena cava  or the  forelimb vein 
(Fig. 1) under loca l  anes thes ia .  34Aort ic  samples  
were obtained from ca the te rs    laced through 
branches of the  brachial  or femoral a r te r ies  (Fig.  
1). In  the smaller  s e r i e s ,  a second  sampling 
catheter  w a s  directed up  the  inferior vena c a v a  
into the h i lus  of the  l iver  for col lect ion of ve- 
nous samples  (Fig. 1). T h i s  permitted simulta- 
neous  eva lua t ions  of both the venous and ar ter ial  
hypoglycemic curves. 
After three or more c o n  t r o 1 samples  were 
taken, glucagon-free insulin* w a s  administered 
intravenously. In the  f i r s t  s e r i e s  of dogs,  insul in 
0.0007 unit/kg./min. w a s  infused constant ly for 
50  minutes. In t h e s e  animals ,  both venous and  
ar ter ial  g lucose  l e v e l s  were obtained by sampling 
every 1 2  minutes  during the  insul in infusion. 
Insul in,  0.0012 unit/kg./min., w a s  a l s o  admin- 
is tered i n  the o t h e r  1 7  dogs a s  a 50 minute 
constant  infusion. In t h i s  group, ar ter ial  samples  
only were  taken every 1 0  minutes. 
Blood s a m p l e s  were p laced  i n  chi l led hepa- 
r inized t e s t  tubes  and centrifuged immediately. 
P l a s m a  g lucose  w a s  determined with a n  auto- 
a n a l y ~ e r , ~  u s i n g  a m a  n i f o 1 d which required 
approximately 0.5 ml. p lasma for ana lys i s .  T h e  
blood l o s s  from sampling, about  3 0  ml., w a s  
replaced ei ther  12 hours  b e f o r e  or jus t  a f te r  
t h e  experiment. 
* S u p p l i e d  by Dr. W. R. Kirtley, E l i  Li l ly  Co., 
Indianapolis. 
t ~ e c h n i c o n  Corporation, Chauncey, New York. 
Table  1 .  - T Values  a n d P  Values  for Control Versus  T i m e  Periods  in Dogs 
Rece iv ing  0.0007 Unit of lnsu l in /kg . /min .  Minutes are 
Time after Onset  of Insulin Infusion 
Degrees 
o f 8 min.* 20 min.* 32 min.* 44 min.* 74 min. 104 min. 148 min. 
Group Freedom Time 1 Time 2 Time 3 Time 4 Time 5 Time 6 Time 7 
Arterial glucose concentration 10 t 5.12 9.36 7.25 9.30 4.71 3.48 2.16 
with sys temic  insulin infusion p 0.05% 0.05% 0.05% 0.05% 0.5% 0.5% 5% 
Arterial glucose concentration 9 t 3.19 5.77 9.95 12.53 5.12 2.67 1.82 
- 
with portal insulin infusion p 1 %  0.05% 0.05% 0.05% 0.05% 2.5% 5% 
*During 50 minute infusion. 
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Table 2. Significance of Route of Administration of Insulin in Dogs 
Receiving 0.0007 unit/kg./min. 
Table 3. x .Values  and P Values for Control Versus Time Periods in Dogs Receiving 
0.001 2 Unit o f 1nsuXn/kg. /min., Expressed as Obs erved Values of Arterial 
Glucose Concentration (mg./100 ml.) and as  a Per cent of Control 
Values Minutes are Time after Start of Insulin lnfusion 
Group 
Arterial  g lucose ,  F 
observed v a l u e s  P 
(sys temic  vs.  
Group 
Degrees  
o f 6 min.* 16 min.* 26 min.* 36 min.* 46 min.* 76 min. 106 min. 
freedom Time 1 Time 2 Time 3 T i m e  4 Time 5 T i m e 6  Time 7 
Interact ion Degrees  
be tween  t imes  of freedom 
47.115 7/133 
1 % 
Arterial  g lucose  concentrat ion,  
observed  v a l u e s  with 
s y s t e m i c  in fus ions  
Arterial  g lucose  concentrat ion,  
observed  v a l u e s  with 
intraportal  infusion 
Interact ion Degrees  
be tween  treatment of freedom 
0.325 1/19 
Not s ign i f ican t  
Arterial  g lucose  concentrat ion 
a s  a % of control  va lue  with 
s y s t e m i c  insu l in  infusion 
T o t a l  D e g r e e s  
in te rac t ion  of freedom 
0.530 7/133 
Not s ign i f ican t  
Arterial  g lucose  concent ra t ion  
a s  a % of control  va lue  with 
portal  insu l in  infusion 
*During 50 minute insu l in  infusion. 
Table 4. Significance of Route of Administration of Insulin in Dogs 
Receiving 0.001 2 Unit/kg. /min. 
Group b Interact ion Degrees  In te rac t ion  Degrees  T o t a l  I D e g r e e s  e tween  t imes  of freedom be tween  treatment of freedom interact ion of freedom 
Arterial  g lucose ,  F 
observed v a l u e s  P 
(sys temic  vs. portal)  
Arterial  g lucose  F 






Not s ign i f ican t  
1.119 1/60 
Not signif icant  
0.319 7/419 
Not s ign i f ican t  
0.417 7/419 
Not s ign i f ican t  
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Two s t a t i s t i c a l  a n a l y s e s  were employed t o  
- .  
determine if the response  to  physiologic  d o s e s  
of insu l in  administered into the  sys temic  circu- 
lation w a s  s ignif icant ly d i f f e r e n t from t h e  
- 
response  t o  insul in administered into t h e  l iver  
via  the intraportal  route. T h e  da ta  from each  s e t  
of experiments  were f i rs t  analvzed to determine 
means,  s tandard  deviat ions and s tandard errors. 
Then  a matched, paired comparison w a s  per- 
formed between t h e  control d a t a  and  the d a t a  
from each sampling time. T h e  resul t ing t va lues  
were then examined to determine the degree of 
probability tha t  the  d a t a  represent ing each  time 
period w a s  from t h e  s a m e  population a s  the  con- 
trol d a t a  ( T a b l e s  1 and  3). T h e  amplitude of the 
t va lue  may a l s o  be  used  to determine the valid- 
i ty  of the response.  Hence,  in  t h i s  s e r i e s  of 
experiments ,  the  t v a l u e s  for each time period 
provide an indicat ion of the  s ignif icance of the 
hypoglycemia ( T a b l e s  1 and 3). 
S e t s  of da ta ,  in  which onlv one variable  w a s  
different,  were analyzed us ing  a s tandard  anal-  
y s i s  of variance. T h e  F i s c h e r  rat ios ,  F, for the  
interaction* between t h e  interact ion be- 
tween t r e a t m e n t s, and the total  interact ion 
(interaction between t imes multiplied by inter- 
act ion b e  t w e e n treatments) were determined 
(Tables  2 and  4). 
T h e  interact ion between t imes represen ts  the  
pooled time interact ion of the two s e t s  of da ta ,  
each represent ing a different treatment. T h e  
F i s c h e r  rat io  i s  an indicat ion of the probability 
tha t  the interact ion did not occur. T h a t  i s ,  if 
t h e  interact ion between times w a s  s ignif icant  a t  
the  1 per  c e n t  level ,  there would be only one 
chance in  a hundred that  the t ime interact ion 
could be  at t r ibuted to  chance. 
In order to  predict  that  a given t rea tmentwas  
s ignif icant ly different from the  other, i t  i s  nec- 
- 
e s s a r y  to examine the i n  t e r a c t i o n between 
treatments. If the  interact ion between t reatments  
i s  s ign i f ican t  a t  t h e  1 per  cen t  level ,  then there 
w a s  only one chance  in  a hundred tha t  the sam- 
p le  taken from each  treatment group w a s  from 
- 
the same population. 
T h u s ,  i t  may be  deduced tha t  although the 
two given treatment groups vary s ignif icant ly i n  
time, they may not be significantly different a s  
far a s  their  mode of treatment i s  concerned. T h e  
converse i s  a l s o  true. 
T h e  to ta l  interact ion should a l s o  be signifi- 
cant  ( T a b l e s  2 and  4) if t h e  interaction between 
times and between t reatments  i s  s ignif icant .  If 
the to ta l  interact ion i s  found to be s ignif icant  
when both interact ion between t imes and between 
t reatments  a r e  not s ignif icant ,  then i t  i s  pos-  
s i b l e  tha t  the  one curve had  a n  effect  that  w a s  
cancel led by t h e  other  ( a s  would be  the c a s e  
when two l inear  curves with s l o p e s  of the op- 
pos i te  s ign  were compared). If,  however, the 
interact ion between times and the interact ion 
between t reatments  a r e  both s ignif icant  and the 
total  interact ion i s  not  s ignif icant ,  then the re- 
s u l t s  a r e  uninterpretable and the d a t a  must 
be reevaluated.  
RESULTS 
Arterial and Venous Response  
to Insul in 0.0007 unit/kg./min. 
Matched experiments  were ~ e r f o r m e d  on s e v e n  
dogs, u s i n g  a l te rna te  rou tes  of administration 
on s u c c e s s i v e  days. E a c h  dog w a s  u s e d  a t  l e a s t  
once for each  route of administration. 
T h e  mean control ar ter ial  plasma sugar  for 
the portal infusion s e r i e s  w a s  9 4  ? 3.4 (S.E.) 
mg./l_OO ml. and  for t h e  systemic s e r i e s  the av- 
erage w a s  9 5  + 3.3 (S.E.) mg./lOO ml. 
With both routes ,  the  maximum ar te r ia l  hypo- 
glycemia occurred 44 minutes  af ter  o n s e t  of t h e  
insul in infusion (Fig. 2). Blood s u g a r  dropped 
to 69 ? 3.1 (S.E.) mg./lOO ml. with portal,  and 
66 ? 2.4 (S.E.) mg./lOO ml. with sys temic  infu- 
sion. T h e  configuration of t h e  hypoglycemic 
curves showed a s l ight ly at tenuated response  
with portal infusion (F ig .  2). Analyses  of vari- 
a n c e  were made u s i n g  both the observed va lues  
(Tables  1 and  2) and t h e  va lues  represented a s  
a per cen t  of their own control ar ter ial  p lasma 
g lucose  concentration. No s ta t i s t i ca l ly  signifi- 
cant  difference between the  r e s p o n s e s  t o  the  
two rou tes  of administration w a s  found by ei ther  
method of computation. 
Arterial and  venous samples  were obtained 
s imultaneously from t h e  femoral artery and the  
portal vein,  j u s t  above the caval-portal anas-  
tomotic junction (Fig. 1). Venous blood from the  
hindquarters  and  k idneys  contr ibutes  to  t h i s  
sample. Venous p lasma g lucose  fa l l  c losely 
paral le led the  ar ter ial  response.  T h e  difference 
between a r te r ia l  and vena cava l  p lasma glucose 
concentrat ions averaged 2.8 ? .43 (S.E.) mg./ 
100 ml. i n  t h e  control  period and ranged between 
2.9 & .54 (S.E.)and 1.3 ? .54 (S.E.) ma./100 ml. 
during insu l in  infusions.  T h e  concentration dif- 
*If  two populations are hypothesized to be  differ- fe rences  were not  s ignif icant ly different with 
ent, the degree to which they overlap i s  referred to the two routes of insulin infusion. 
a s  interaction. 
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TIME IN MINUTES 
Fig. 2. Effec t  of insu l in  infusion (0.0007unit/kg./min.)upon ar te r ia l  p lasma g lucose  concentrat ion given 
by s y s t e m i c  and intraportal  rou tes .  Mean v a l u e s  and s tandard  errors  a re  represen ted  by d o t s  and ver t ica l  b a r s  
respec t ive ly .  T h e  apparent  difference in l a t e  e f fec t  with the  two routes  w a s  no t  s t a t i s t i c a l l y  s ign i f ican t .  
f 2.3 (S.E.) before intraportal and sys temic  in- 
Arterial R e s p o n s e  to su l in  administration respectively. 
Insul in 0.0012 unit/kg./ml. With intraportal infusion, the maximum hypo- 
glycemia w a s  65 mg./lOO ml. + 1.7 (S.E.) and  
Sixty-two paired experiments were performed occurred 46 minutes  af ter  the  onse t  of insu l in  
on 17 dogs ;  in 3 1  insul in w a s  infused by sY s- infusion. With sys temic  infusion, the lowes t  
temic route  and in 3 1  by intraportal route-  T h e  plasma g lucose  concentration w a s  68 mg./lOO 
mean control plasma g lucose  concentration was  2 2.3(S.E.), and a l s o  occurred a t  46 minutes  
9 2  rng./lOO ml. + 1.9 (S.E.) and 9 3  mg./lOO ml. ( ~ i ~ .  3). 
I I ----- INTRAPORTAL INFUSION 
! 1 
0 10 2 0  3 0  4 0  5 0  $O 7b 8 0  9 0  100 110 
TIME IN MINUTES 
Fig. 3. Effec t  of insu l in  infusion (0.0012 unit/kg./min.) upon arterial  p lasma g lucose  with sys temic  
compared to  por ta l  administrat ion of insu l in .  Mean v a l u e s  and standard errors  a r e  represen ted  by d o t s  and 
vert ical  b a r s  respec t ive ly .  There  w a s  n o  s ign i f ican t  difference in e f fec t  with the  two routes  of infusion.  
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T h e  configuration of the curves w a s  almost  
ident ical  (Fig.  3). Analyses  of var iance u s i n g  
both observed va lues  and percentage of control 
values indicated no s ignif icant  difference in  the 
e f fec t s  of insul in given by the  two rou tes  of ad- 
ministration ( T a b l e s  3 and 4). 
DISCUSSION 
For  a n u m b e r  of years ,  the  concept  h a s  
been gaining popularity that  the  l iver  moder- 
a t e s  or par t ia l ly  controls  the  effect  of insu l in  
by virtue of i t s  capaci ty for inact ivat ion of t h e  
hormone. 2 3 * 2 4 w 3 6  Metz and B e s t  have  s u g g e s t e d  
that  therapeut ical ly  administered insul in may be 
the "right drug by the wrong route."23 S te t ten36  
postulated t h e  role  of the  liver a s  a guardian 
mechanism sh ie ld ing  the organism from "un- 
wanted hormone." Egdahl  and h i s  a s s o c i a t e s 6  
have  evidence that  the  l iver  t raps  in- 
su l in  (or insulin-like activity) af ter  g l u c o s e  
infusions a n d  later  r e l e a s e s  i t .  
Several  considerat ions have made s u c h  a 
hypothesis  a t t ract ive.  F i r s t  i s  the anatomic 
fac t  t h a t  endogenous insul in i s  a l l  e laborated 
into the  portal  circulation. Reports  by Mirsky 
and others  1 5 * 2 4 - 2 7 * 2 9 * 3 8 * 3 9 ~ 4 5  of semi-specif ic  
enzyme s y s t e m s  in hepa t ic  parenchyma which 
inact ivated i n s u l i n ~ r o v i d e d  a ~ o s s i b l e  degrada- 
tion mechanism. T h e  la te r  discovery tha t  I 3 1  
insul in is se lec t ive ly  concentrated in  
1 6 * 1 9 * 2 8 * 4 4  could be interpreted along s imi la r  
l ines .  F ina l ly ,  M a d i s o n  and  h i s  assoc i -  
a t e s  1 8 * 2 0 * 2 1  have detected differences i n  the  
mechanism of  hypoglyceniia with portal a s  op- 
posed  to sys temic  injection of insulin. 
E s s e n t i a l  t o  confirmation of such  a theory of 
hepat ic  inact ivat ion i s  the demonstration of a 
difference i n  physiologic effect  of insul in infused 
directly into the  l iver  v i a  the  portal vein a s  op- 
posed t o  sys temic  administration. A large but 
incons i s ten t  bulk of evidence h a s  accumulated 
on t h i s  s u b j e c t  in the  l a s t  thirty years .  About 
half the inves t iga t ions  have sugges ted  that  the 
two rou tes  of inject ion resu l t  in  an ident ical  hy- 
poglycemic response.  's3* l o *  4 * 2 0 . 3 0 - 3  w 3 3  T h e  
other half ind ica te  that  portal inject ion i s  l e s s  
effect ive than  systemic.  4 * B * 9 *  4 * 2 2 * 3 7 * 4 2  The  
d i spara te  r e s u l t s  may be due to differences and 
diff icul t ies  i n  experimental methods. T h e s e  in- 
c lude the u s e  of glucagon-contaminated insul in,  
anes thes ia ,  recen t  surgery, insuff icient  numbers 
of experiments, comparative tes t ing  a t  too short  
time in te rva l s ,  t e s t i n g  with large or  rapidly given 
d o s e s ,  var iat ions in fast ing,  use  of subcutaneous  
inject ion techniques and failure to  s u b j e c t  re- 
s u l t s  t o  adequa te  s t a t i s t i c a l  evaluation. 
T h e  experimental protocol followed in the 
present  s tudy  w a s  designed to avoid or evaluate  
t h e s e  object ions.  Many of the advantages  of the 
experimental  model a r e  due to the  u s e  of dogs 
with t ransposi t ion.  Although the  v a s c u l a r  flow 
i s  a l tered in t h e s e  animals ,  hepat ic  blood flow 
and l iver  function a re  e s s e n t i a l l y  normal. ' 3 * 3 2 * 3 5  
Prev ious  s t u d i e s  have  demonstrated that  the 
operation of portacaval  t ransposi t ion d o e s  not 
by i t se l f  c a u s e  any change in insulin respon- 
s i v e n e s s .  33  
In ear l ier  s t u d i e s ,  i t  w a s  shown that  relat ively 
large and rapidly in jec ted  d o s e s  of insul in re- 
s u l t e d  i n  the  s a m e  h y p o g 1 y c e m i  c response ,  
w h e t h e r  given by a transportal or sys temic  
route. T h e  presen t  s tudy,  employing smal l  
d o s e s  of insul in with prolonged cons tan t  infu- 
s ion ,  h a s  yielded s imilar  resul ts .  comparabi l i ty  
of e f fec t  with the two routes  w a s  presen t  in  both 
the ar ter ial  and venous samples.  
T h e  presen t  s tudy d o e s  notprovide corrobora- 
tion for the  belief that  the l iver  inf luences the 
action of insul in under the  condit ions and cir- 
cumstances  of t h e s e  e x  p e r i m e n  t s. T h e  data  
provide l i t t l e  hope tha t  diversion of endogenous 
insul in into sys temic  venous channe ls  would 
enhance i t s  effect iveness .  Neither potent iat ion 
nor obtundation of hypoglycemic effect w a s  
demonstrated with primary passage  of insul in 
through t h e  liver. T h e s e  findings would appear  
t o  be important in  eva lua t ing  the s ignif icance 
of related research.  F o r  example, the s e l e c t i v e  
fixation of  I 3 1  i n s u l i n  by the l iver  may not 
necessar i ly  be equated with a l o s s  of physiologic 
activity. If hepa t ic  detoxifying mechanisms in- 
volving insu l inase  or other enzymes e x i s t  they 
a re  not a p p a r e n t  under the c i rcumstances  of 
t h e s e  experiments. 
SUMMARY 
T h e  hyperglycemic effect  of insul in by pro- 
longed intrapoi tal  and  sys temic  infusion w a s  
measured in unanes the t ized  dogs with a modi- 
fied portacaval  transposition. There w a s  no 
s ignif icant  difference i n  response  with the  two 
rou tes  of administration. T h e  relat ion of t h e s e  
resu l t s  t o  research  directed to  surgical  therapy 
of d iabe tes  is d iscussed .  
Mr. Kenneth Lawton o f  Chicago provided invalu- 
able a s s i s t ance  in the postsurgical  care  and training 
of the dogs in the performance of the experiments. 
The authors gratefully acknowledge the  a s s i s t ance  
given by Mr. Ronald Olson in programming and op- 
erating the  digital computer. 
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